Company Filing History:
Years Active: 2025
Title: Anke Mayer-Bartschmid: Innovator in Antibody Engineering
Introduction
Anke Mayer-Bartschmid is a notable inventor based in Wülfrath, Germany. She has made significant contributions to the field of antibody engineering, particularly through her innovative patent related to Atrial Natriuretic Peptide (ANP) engrafted antibodies. Her work exemplifies the intersection of biotechnology and therapeutic development.
Latest Patents
Anke holds a patent for "Atrial natriuretic peptide engrafted antibodies." This invention pertains to an antibody or a fragment that includes at least one heterologous amino acid sequence within its Complementarity Determining Regions (CDR). The patent describes the incorporation of an N-terminal linker sequence, an Atrial Natriuretic Peptide, and a C-terminal linker sequence. Additionally, it outlines the use of this antibody in treatment methods, compositions, and the processes for producing such antibodies.
Career Highlights
Throughout her career, Anke has worked with prominent companies in the pharmaceutical industry, including Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft. Her experience in these organizations has allowed her to develop her expertise in antibody research and therapeutic applications.
Collaborations
Anke has collaborated with several professionals in her field, including Damian Brockschnieder and Marcel Geertz. These collaborations have contributed to her innovative work and the advancement of antibody engineering.
Conclusion
Anke Mayer-Bartschmid is a pioneering inventor whose work in antibody engineering has the potential to impact therapeutic treatments significantly. Her contributions to the field are marked by her innovative patent and her collaborations with industry professionals.